Gene News and Research

Latest Gene News and Research

International team of researchers joins forces to decode genome of prehistoric fish

An enigmatic prehistoric fish has brought scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) together with researchers from all over the world to crack its genomic code.

22 Apr 2013

Loss or amplification of particular DNA regions contributes to the development of prostate cancer

A new analysis has found that the loss or amplification of particular DNA regions contributes to the development of prostate cancer, and that patients with two of these DNA changes have a high likelihood of dying from the disease.

22 Apr 2013

Xenon Pharmaceuticalsn receives BIOTECanada's Gold Leaf Company of the Year Award for 2013

Xenon Pharmaceuticals Inc. is pleased to announce that it has been awarded BIOTECanada's Gold Leaf Company of the Year Award for 2013.

22 Apr 2013

Phase 2 study of VX-661 and ivacaftor shows significant improvements in lung function among CF patients

Vertex Pharmaceuticals Incorporated today announced data from a Phase 2 study of VX-661 and ivacaftor that showed statistically significant improvements in lung function among adults with cystic fibrosis (CF) who have two copies (homozygous) of the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, known as F508del.

22 Apr 2013

Advanced microscope reveals process where mutations lead to autism and other diseases

Using spinning disk microscopy on barely day-old zebra fish embryos, University of Oregon scientists have gained a new window on how synapse-building components move to worksites in the central nervous system.

22 Apr 2013

Mirus Bio to use CSIRO's RAFT Polymerization Technology to expedite its product development efforts

CSIRO and Mirus Bio LLC are pleased to announce a new license arrangement that will enable Mirus Bio to utilize the unique characteristics of CSIRO's Reversible Addition-Fragmentation chain Transfer polymerisation technology (RAFT) to expand upon its high-end polymer development capabilities for the biotech industry.

22 Apr 2013

Penn researcher wins Distinguished Clinical Research Achievement Award for innovations in gene therapy

A gene therapy study focused on finding a cure for a rare congenital blinding disease has been recognized as one of the ten most outstanding clinical research projects of the year by the Clinical Research Forum (CRF).

22 Apr 2013

Study identifies potential drug targets that interfere with cancer metabolism

A massive study analyzing gene expression data from 22 tumor types has identified multiple metabolic expression changes associated with cancer.

22 Apr 2013

Genetic study defines link between primary sclerosing cholangitis and other autoimmune diseases

Researchers have newly associated nine genetic regions with a rare autoimmune disease of the liver known as primary sclerosing cholangitis (PSC). This brings the total number of genetic regions associated with the disease to 16.

22 Apr 2013

Researchers decipher the underlying mechanism of antiviral drug

A long-forgotten candidate for antiviral therapy is undergoing a renaissance: Since the 1970s, the small molecule CMA has been considered a potent agent against viral infections, yet it was never approved for clinical use.

22 Apr 2013

Researchers find new potential target for anti-telomerase cancer therapy

Researchers at UT Southwestern Medical Center have found that alternative splicing - a process that allows a single gene to code for multiple proteins - appears to be a new potential target for anti-telomerase cancer therapy.

20 Apr 2013

Monoclonal antibody inhibits tumor growth in angiosarcoma and breast cancer

A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.

20 Apr 2013

Ceregene announces top-line data from CERE-12 Phase 2b clinical study for Parkinson's disease

Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease.

20 Apr 2013

Penn Medicine gene therapy study receives Distinguished Clinical Research Achievement Award

20 Apr 2013

Editorials address China's response to emergence of H7N9 bird flu strain

"The H7N9 strain contains gene sequences that make it relatively effective, for a bird virus, at infecting humans and other mammals," Bloomberg writes.

20 Apr 2013

Study identifies seven new genetic regions associated with pulmonary fibrosis

A new genome-wide association study of more than 6,000 people has identified seven new genetic regions associated with pulmonary fibrosis. In findings published online in Nature Genetics on April 14, 2013, researchers at National Jewish Health, the University of Colorado and several other institutions found a number of genes associated with host defense, cell-cell adhesion and DNA repair, which provide clues to possible mechanisms underlying this currently untreatable disease.

20 Apr 2013

Vision expo to offer rehabilitation information to blind and visually impaired patients

A daylong vision expo will be held Saturday, April 20 at the University of Houston (UH), offering information on rehabilitation and resources for the blind and visually impaired to live independent and productive lives.

19 Apr 2013

BIIR researchers report results of comparative study of molecular immune responses to influenza and pneumococcal vaccines

In a manuscript published today in Immunity, scientists at the Baylor Institute for Immunology Research (BIIR) and the Benaroya Research Institute at Virginia Mason report the results of a comparative study of the molecular immune responses to influenza and pneumococcal vaccines.

19 Apr 2013

Combination therapies may advance treatment for anaplastic thyroid cancer

A combination of therapies may prove to be a promising advance for the treatment of anaplastic thyroid cancer based on results of a phase I clinical trial, say researchers at Mayo Clinic in Florida.

19 Apr 2013

Three MGH projects named among Top 10 Clinical Research Achievements of 2012

Three projects led by Massachusetts General Hospital investigators have been named among the Clinical Research Forum's Top 10 Clinical Research Achievements of 2012.

19 Apr 2013

Gene News and Research

Latest Gene News and Research

International team of researchers joins forces to decode genome of prehistoric fish

Loss or amplification of particular DNA regions contributes to the development of prostate cancer

Xenon Pharmaceuticalsn receives BIOTECanada's Gold Leaf Company of the Year Award for 2013

Phase 2 study of VX-661 and ivacaftor shows significant improvements in lung function among CF patients

Advanced microscope reveals process where mutations lead to autism and other diseases

Mirus Bio to use CSIRO's RAFT Polymerization Technology to expedite its product development efforts

Penn researcher wins Distinguished Clinical Research Achievement Award for innovations in gene therapy

Study identifies potential drug targets that interfere with cancer metabolism

Genetic study defines link between primary sclerosing cholangitis and other autoimmune diseases

Researchers decipher the underlying mechanism of antiviral drug

Researchers find new potential target for anti-telomerase cancer therapy

Monoclonal antibody inhibits tumor growth in angiosarcoma and breast cancer

Ceregene announces top-line data from CERE-12 Phase 2b clinical study for Parkinson's disease

Penn Medicine gene therapy study receives Distinguished Clinical Research Achievement Award

Editorials address China's response to emergence of H7N9 bird flu strain

Study identifies seven new genetic regions associated with pulmonary fibrosis

Vision expo to offer rehabilitation information to blind and visually impaired patients

BIIR researchers report results of comparative study of molecular immune responses to influenza and pneumococcal vaccines

Combination therapies may advance treatment for anaplastic thyroid cancer

Three MGH projects named among Top 10 Clinical Research Achievements of 2012

Industry Focus: Cell & Gene Therapy eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier